Overview

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Status:
NOT_YET_RECRUITING
Trial end date:
2027-03-10
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Phase:
PHASE3
Details
Lead Sponsor:
Gan & Lee Pharmaceuticals.